Skip to main content [Access key M]
Jump to the site map [Access key S]
Skip to the second level navigation [Access key L]
Return to main site navigation [Access key N]
Annual Review and
Summary Financial Statement 2005
search

Financial Review

£ millions 2004
(52 weeks)
Base
Business
Acquisitions/
Disposals
Exchange 2005
Revenue 1,041 81 1 34 1,157
- year-on year change   +8% +0% +3% +11%
Underlying Profit from Operations 132 19 - 6 157
- year-on year change   +14% +0% +5% +19%
Underlying Operating Margin 12.7%       13.5%

Our business across the Asia Pacific region had an excellent year with a particularly strong second half performance. We had good results in both our developed and emerging market businesses which grew at 7% and 11% respectively. Shares were increased in most major markets and all categories showed good growth in revenues.

Our confectionery operations in Australia and New Zealand grew revenues by 7% following a number of highly successful new product launches in Australia (Cadbury Caramel Whip, Boost and Brunch Bar) and share recovery in New Zealand. Our beverage business in Australia grew revenues by 7% despite discontinuing a number of its smaller less profitable brands. In Japan, innovation in gum, particularly in the Clorets and Whiteen brands, led to a 140 basis point increase in share to 16.8% and a further improvement in margins.

In emerging markets, India grew strongly with revenues up 14% and chocolate share ahead by 120 basis points to 70.5%. Performance was also boosted by a resurgence in our business in Pakistan. In South East Asia, we continued to extend our share leadership in gum in Thailand (by 80 basis points to 58.9%), driven by the focus on sugar-free gum. The successful launch of Dentyne in Malaysia, using product sourced from our Thailand operations, saw our gum share increase by nearly 10 percentage points to 17.0%. In China, where we have been refocusing the business, revenues were 11% ahead as we relaunched our Cadbury Dairy Milk range.

Margins in the region were 80 basis points ahead due to the benefits of cost reduction projects and a focus on profitable growth. Key efficiency projects during the year included supply chain optimisation in Australia and New Zealand; manufacturing consolidation in China; and automation of Bournvita production in India.

I'm interested in